Price Alert

BeOne Medicines Ltd. (ONC)

NASDAQ: ONC · Real-Time Price · USD

321.57

11.88 (3.84%)

At close: Aug 15, 2025, 3:59 PM

321.98

0.13%

After-hours: Aug 15, 2025, 04:24 PM EDT

BeOne Medicines Statistics

Share Statistics

BeOne Medicines has 110.03M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	110.03M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	6
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 1.62M, so 1.5% of the outstanding shares have been sold short.

Short Interest	1.62M
Short % of Shares Out	1.5%
Short % of Float	2.15%
Short Ratio (days to cover)	5.16

Valuation Ratios

The PE ratio is -30.16 and the forward PE ratio is 46.5. BeOne Medicines's PEG ratio is 1.09.

PE Ratio	-30.16
Forward PE	46.5
PS Ratio	5.1
Forward PS	4.8
PB Ratio	5.84
P/FCF Ratio	-29.04
PEG Ratio	1.09

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BeOne Medicines.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.8, with a Debt / Equity ratio of 0.32.

Current Ratio	1.8
Quick Ratio	1.58
Debt / Equity	0.32
Debt / EBITDA	-2.72
Debt / FCF	-1.61
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$346.39K
Profits Per Employee	$-58.62K
Employee Count	11,000
Asset Turnover	0.64
Inventory Turnover	1.2

Taxes

Income Tax	111.78M
Effective Tax Rate	-20.97%

Stock Price Statistics

The stock price has increased by 52.44% in the last 52 weeks. The beta is 0.27, so BeOne Medicines's price volatility has been higher than the market average.

Beta	0.27
52-Week Price Change	52.44%
50-Day Moving Average	269.54
200-Day Moving Average	234.5
Relative Strength Index (RSI)	52.13
Average Volume (20 Days)	377,701

Income Statement

In the last 12 months, BeOne Medicines had revenue of 3.81B and earned -644.79M in profits. Earnings per share was -6.12.

Revenue	3.81B
Gross Profit	3.22B
Operating Income	-568.2M
Net Income	-644.79M
EBITDA	-396.44M
EBIT	-568.2M
Earnings Per Share (EPS)	-6.12

Full Income Statement

Balance Sheet

The company has 2.63B in cash and 1.08B in debt, giving a net cash position of 1.55B.

Cash & Cash Equivalents	2.63B
Total Debt	1.08B
Net Cash	1.55B
Retained Earnings	-8.61B
Total Assets	6.3B
Working Capital	2.1B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -140.63M and capital expenditures -529.14M, giving a free cash flow of -669.77M.

Operating Cash Flow	-140.63M
Capital Expenditures	-529.14M
Free Cash Flow	-669.77M
FCF Per Share	-6.36

Full Cash Flow Statement

Margins

Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.

Gross Margin	84.41%
Operating Margin	-14.91%
Pretax Margin	-13.99%
Profit Margin	-16.92%
EBITDA Margin	-10.4%
EBIT Margin	-14.91%
FCF Margin	-17.58%

Dividends & Yields

ONC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for ONC is $339.5, which is 17.2% higher than the current price. The consensus rating is "Buy".

Price Target	$339.5
Price Target Difference	17.2%
Analyst Consensus	Buy
Analyst Count	10

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	6.71
Piotroski F-Score	6